No CrossRef data available.
Article contents
Putting contract research organisations on the radar
Published online by Cambridge University Press: 02 January 2018
Extract
There is a trend for pharmaceutical companies to contract third parties to conduct the clinical trials that are needed to test their drugs. This trend is referred to as outsourcing, and the companies that carry out the work are called contract research organisations. In addition, clinical trials are increasingly conducted in non-traditional trial regions, which are mainly low-and middle-income countries. This trend is called offshoring. The combination of outsourcing and offshoring poses serious risks for the ethical treatment of participants in clinical trials.
- Type
- Thematic papers
- Information
- Creative Commons
- This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
- Copyright
- Copyright © Royal College of Psychiatrists 2012
Footnotes
This article is based on a research report with the same title, published by the Centre for Research on Multinational Corporations (SOMO), Corporate Social and Ethical Research (CSER) and Salud y Farmacos (SyF). It is available from SOMO's website, http://somo.nl/publications-nl/Publication_3615-nl
eLetters
No eLetters have been published for this article.